Literature DB >> 24691612

Academic medical center leadership on pharmaceutical company boards of directors.

Timothy S Anderson1, Shravan Dave2, Chester B Good3, Walid F Gellad3.   

Abstract

Mesh:

Year:  2014        PMID: 24691612     DOI: 10.1001/jama.2013.284925

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Plastic Surgeons as Medical Directors: A Natural Transition into Medical Leadership.

Authors:  Faryan Jalalabadi; Andrew M Ferry; Andrew Chang; Edward M Reece; Shayan A Izaddoost; Victor J Hassid; Youssef Tahiri; Edward P Buchanan; Sebastian J Winocour
Journal:  Arch Plast Surg       Date:  2022-04-06

2.  Prevalence and compensation of academic leaders, professors, and trustees on publicly traded US healthcare company boards of directors: cross sectional study.

Authors:  Timothy S Anderson; Chester B Good; Walid F Gellad
Journal:  BMJ       Date:  2015-09-29

3.  Perceived conflict of interest in health science partnerships.

Authors:  John C Besley; Aaron M McCright; Nagwan R Zahry; Kevin C Elliott; Norbert E Kaminski; Joseph D Martin
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

Review 4.  Mapping conflict of interests: scoping review.

Authors:  Susan Chimonas; Maha Mamoor; Sophia A Zimbalist; Brooke Barrow; Peter B Bach; Deborah Korenstein
Journal:  BMJ       Date:  2021-11-03

5.  Evaluation of Industry Relationships Among Authors of Otolaryngology Clinical Practice Guidelines.

Authors:  Jarryd Horn; Jake Xavier Checketts; Omar Jawhar; Matt Vassar
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-03-01       Impact factor: 6.223

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.